Skip to Content

Cefpodoxime

Last Updated: September 27, 2016
Status: Resolved

Products Affected - Description
    • Cefpodoxime oral suspension, Aurobindo, 100 mg/5 mL, 100 mL bottle, 1 count, NDC 65862-0141-01
    • Cefpodoxime oral suspension, Aurobindo, 100 mg/5 mL, 50 mL bottle, 1 count, NDC 65862-0141-50
    • Cefpodoxime oral suspension, Aurobindo, 50 mg/5 mL, 100 mL bottle, 1 count, NDC 65862-0140-01
    • Cefpodoxime oral suspension, Aurobindo, 50 mg/5 mL, 50 mL bottle, 1 count, NDC 65862-0140-50
    • Cefpodoxime oral suspension, Sandoz, 100 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6169-52
    • Cefpodoxime oral suspension, Sandoz, 50 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6168-46
    • Cefpodoxime oral suspension, Sandoz, 50 mg/5 mL, 50 mL bottle, 1 count, NDC 00781-6168-52
Reason for the Shortage
    • Aurobindo discontinued cefpodoxime oral suspension.
    • Pfizer has discontinued Vantin.
    • Ranbaxy has an import ban on all solid medications including cefpodoxime.
    • Sandoz could not provide a reason for the shortage. They have discontinued 50 mg/mL 50 mL and 100 mL oral suspension and 100 mg/mL 50 mL oral suspension.
Available Products
    • Cefpodoxime oral tablet, Aurobindo, 100 mg, 20 count, NDC 65862-0095-20
    • Cefpodoxime oral tablet, Aurobindo, 200 mg, 20 count, NDC 65862-0096-20
    • Cefpodoxime oral suspension, Sandoz, 100 mg/5 mL, 100 mL bottle, 1 count, NDC 00781-6169-46
    • Cefpodoxime oral tablet, Sandoz, 100 mg, 20 count, NDC 00781-5438-20
    • Cefpodoxime oral tablet, Sandoz, 200 mg, 20 count, NDC 00781-5439-20
    • Cefpodoxime oral tablet, Sandoz, 200 mg, 100 count, NDC 00781-5439-01

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated September 27, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 20, 2011 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide